Trade Mark Journal No.2026/023 5 June 2026

WO0000001918251 (9,42,44)

Office of origin: European Union Intellectual Property Office (EUIPO)

Date of International Registration:7 April 2026
Date of designation in the UK: 7 April 2026
Image for mark 1918251_TIF WAIV

International priority date claimed: 3 November 2025 (European Union Intellectual Property Office (EUIPO)) (019270421)
Class 9
Scientific research apparatus and instruments intended for laboratories for analysis and reporting regarding pathology specimens in relation to the following fields: oncology; laboratory robots with artificial intelligence for scientific research in the field of oncology; recorded software for diagnostic support in relation to the following fields: oncology; recorded software for medical imaging analysis in relation to the following fields: oncology; computer programs and software enabling health status diagnosis, prescription of treatments and prescriptions, design of clinical trials and prediction of clinical trial outcomes, search for clinical trial participants, analysis of medical images, data analysis and development of pharmaceutical products and chemical compounds.
Class 42
Scientific, technological and medical research services in the field of oncology; scientific-technological services, namely, clinical trial design, data analysis, projection of clinical trial results, and therapeutic decision support, in the field of oncology; online provision of non-downloadable software for diagnostic support in the field of oncology; online provision of non-downloadable software for medical imaging analysis in the field of oncology; Software as a Service (SaaS) services featuring software for diagnostic support in the field of oncology; Software as a Service (SaaS) services featuring software for medical imaging analysis in the field of oncology; Software as a Service [SaaS] enabling health status analysis, prescription of treatments and prescriptions, design of clinical trials and prediction of clinical trial outcomes, search for clinical trial participants, analysis of medical images, data analysis and development of pharmaceutical products and chemical compounds.
Class 44
Medical services; medical diagnosis services; information and advisory services relating to pharmaceutical products; medical services in the field of oncology.

Owkin DX

Representative: FIELDFISHER (FRANCE) LLP, 48 Rue Cambon, F-75001 Paris, FRANCE